tetano
Editor, Senior Moderator
Microbes Infect
. 2021 Jun 4;104843.
doi: 10.1016/j.micinf.2021.104843. Online ahead of print.
Comparative Immunogenicity Analysis of Intradermal versus Intramuscular Administration of SARS-CoV-2 RBD Epitope Peptide-based Immunogen In vivo
Naveen Yadav[SUP] 1 [/SUP], Preeti Vishwakarma[SUP] 1 [/SUP], Ritika Khatri[SUP] 1 [/SUP], Gazala Siddqui[SUP] 1 [/SUP], Amit Awasthi[SUP] 1 [/SUP], Shubbir Ahmed[SUP] 1 [/SUP], Sweety Samal[SUP] 2 [/SUP]
Affiliations
Abstract
COVID-19 pandemic has caused severe disruption of global health and devastated the socio-economic conditions all over the world. The disease is caused by SARS-CoV-2 virus that belongs to the family of Coronaviruses which are known to cause a wide spectrum of diseases both in humans and animals. One of the characteristic features of the SARS-CoV-2 virus is the high reproductive rate (R[SUB]0[/SUB]) that results in high transmissibility of the viruses between humans. Vaccines are the best option to prevent and control this disease. Though, the traditional intramuscular (IM) route of vaccine administration is one of the effective methods for induction of antibody response, a needle-free self-administrative intradermal (ID) immunization will be easier for SARS-CoV-2 infection containment, as vaccine administration method will limit human contacts. Here, we have assessed the humoral and cellular responses of a RBD-based peptide immunogen when administered intradermally in BALB/c mice and side-by-side compared with the intramuscular immunization route. The results demonstrate that ID vaccination is well tolerated and triggered a significant magnitude of humoral antibody responses as similar to IM vaccination. Additionally, the ID immunization resulted in higher production of IFN-γ and IL-2 suggesting superior cellular response as compared to IM route. Overall, our data indicates immunization through ID route provides a promising alternative approach for the development of self-administrative SARS-CoV-2 vaccine candidates.
Keywords: Intradermal immunization; RBD peptide; SARS-COV-2; humoral and cellular responses; vaccine.
. 2021 Jun 4;104843.
doi: 10.1016/j.micinf.2021.104843. Online ahead of print.
Comparative Immunogenicity Analysis of Intradermal versus Intramuscular Administration of SARS-CoV-2 RBD Epitope Peptide-based Immunogen In vivo
Naveen Yadav[SUP] 1 [/SUP], Preeti Vishwakarma[SUP] 1 [/SUP], Ritika Khatri[SUP] 1 [/SUP], Gazala Siddqui[SUP] 1 [/SUP], Amit Awasthi[SUP] 1 [/SUP], Shubbir Ahmed[SUP] 1 [/SUP], Sweety Samal[SUP] 2 [/SUP]
Affiliations
- PMID: 34098108
- DOI: 10.1016/j.micinf.2021.104843
Abstract
COVID-19 pandemic has caused severe disruption of global health and devastated the socio-economic conditions all over the world. The disease is caused by SARS-CoV-2 virus that belongs to the family of Coronaviruses which are known to cause a wide spectrum of diseases both in humans and animals. One of the characteristic features of the SARS-CoV-2 virus is the high reproductive rate (R[SUB]0[/SUB]) that results in high transmissibility of the viruses between humans. Vaccines are the best option to prevent and control this disease. Though, the traditional intramuscular (IM) route of vaccine administration is one of the effective methods for induction of antibody response, a needle-free self-administrative intradermal (ID) immunization will be easier for SARS-CoV-2 infection containment, as vaccine administration method will limit human contacts. Here, we have assessed the humoral and cellular responses of a RBD-based peptide immunogen when administered intradermally in BALB/c mice and side-by-side compared with the intramuscular immunization route. The results demonstrate that ID vaccination is well tolerated and triggered a significant magnitude of humoral antibody responses as similar to IM vaccination. Additionally, the ID immunization resulted in higher production of IFN-γ and IL-2 suggesting superior cellular response as compared to IM route. Overall, our data indicates immunization through ID route provides a promising alternative approach for the development of self-administrative SARS-CoV-2 vaccine candidates.
Keywords: Intradermal immunization; RBD peptide; SARS-COV-2; humoral and cellular responses; vaccine.